OCX stock news

OncoCyte surprises us again with an acquisition, this time it has been Insight Genetics (IG). This acquisition enables OCX to enter into the oncological immunot Read more

5 Stocks To Watch For January 13, 2020

05:11am, Monday, 13'th Jan 2020
Some of the stocks that may grab investor focus today are: OncoCyte Corp (NYSE: OCX) announced plans to acquire Insight Genetics for $12 million. OncoCyte … Read more
OncoCyte Corp (NYSEAMERICAN:OCX) – Equities research analysts at Piper Jaffray Companies reduced their FY2023 earnings per share estimates for OncoCyte in a report issued on Thursday, November 14th. Piper Jaffray Companies analyst W. Quirk now forecasts that the biotechnology company will earn $0.12 per share for the year, down from their prior estimate of $0.14. […] Read more
Chardan Capital reissued their buy rating on shares of OncoCyte (NYSEAMERICAN:OCX) in a research report report published on Friday, TipRanks reports. The firm currently has a $7.75 target price on the biotechnology company’s stock. Separately, Zacks Investment Research downgraded OncoCyte from a buy rating to a hold rating in a research note on Wednesday, July […] Read more
OncoCyte Corp (NYSEAMERICAN:OCX) major shareholder Broadwood Partners, L.P. purchased 1,176,471 shares of the business’s stock in a transaction dated Wednesday, November 13th. The stock was bought at an average cost of $1.70 per share, with a total value of $2,000,000.70. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which […] Read more
OncoCyte Corp (NYSEAMERICAN:OCX) has earned an average recommendation of “Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year price target among analysts that have issued a report […] Read more
DetermaVu CLIA Validation Remains On-Track for Q1 2020 Completion Acquisition of Razor Genomics Lung Cancer Treatment Stratification Test with Proposed CMS Positive Coverage Decision … | November 14, 2019 Read more
GO2 Foundation was founded by patients and survivors of lung cancer and is the world’s leading organization dedicated to saving, extending and improving the lives of those vulnerable, at risk and diagnosed with lung cancer. Read more
OncoCyte Corporation (NYSE American: OCX), a molecular diagnostics company providing actionable answers at critical decision points across the cancer care continuum, today announced the company will present data at AMCP Nexus 2019, being held October 29-November 1, 2019 at the Gaylord National Hotel Read more
Does the July share price for OncoCyte Corporation (NYSEMKT:OCX) reflect what it's really worth? Today, we will… Read more
OncoCyte (OCX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes. Read more
OCX earnings call for the period ending March 31, 2019. Read more
OncoCyte Corporation (NYSEMKT:OCX) Q1 2019 Earnings Conference Call May 14, 2019, 04:30 PM ET Company Participants Bob Yedid - IR, LifeSci Advisors William Anne Read more

OncoCyte beats by $0.01

08:24pm, Tuesday, 14'th May 2019
Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At